Mylan loses bid to have US Teva patent infringement suit on Copaxone tossed out
31 August 2011
Nancy Faigen
Please Login to read the full article.
31 August 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Teva in US agrees to 2017 for Vytorin generic, as Merck has other pending cases
- Sanofi loses again, as US judge upholds FDA's different generic 'sameness' criteria
- US Capitol Capsule: Court rulings in gene patent, stem cell cases provide new hope for biopharma
- Mylan fails to nix Tarceva patent leaving Astellas, Roche and Pfizer clear until 2018
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
